Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Nutt, P. Glue (1989)
Clinical pharmacology of anxiolytics and antidepressants: A psychopharmacological perspectivePharmacology & Therapeutics, 44
NJUNG'E NJUNG'E, HANDLEY HANDLEY (1991)
Evaluation of marble burying as a model of anxietyPharmacol. Biochem. Behav., 38
NUTT NUTT, GLUE GLUE (1989)
Clinical pharmacology of anxiolytics: a psychopharmacological perspectivePharmacol. Ther., 44
M. Hamon, J. Cossery, U. Spampinato, H. Gozlan (1986)
Are there selective ligands for 5-HT1A and 5-HT1B receptor binding sites in brain?Trends in Pharmacological Sciences, 7
C. Broekkamp, H. Berendsen, F. Jenck, A. Delft (1989)
Animal models for anxiety and response to serotonergic drugs.Psychopathology, 22 Suppl 1
TREIT TREIT (1985)
Animal models for the study of anti‐anxiety agents: a reviewNeurosci. Behav. Rev., 9
J. Gray (1985)
The neuropsychology of anxiety.Issues in mental health nursing, 7 1-4
G. Goodwin, A. Green (1985)
A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5‐HT1 and 5‐HT2 receptorsBritish Journal of Pharmacology, 84
D. Treit (1985)
Animal models for the study of anti-anxiety agents: A reviewNeuroscience & Biobehavioral Reviews, 9
A. Poling, J. Cleary, M. Monaghan (1981)
Burying by rats in response to aversive and nonaversive stimuli.Journal of the experimental analysis of behavior, 35 1
J. Arnt, John Hyttel (1989)
Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI.European journal of pharmacology, 161 1
D. Pettibone, Michael Williams (1984)
Serotonin-releasing effects of substituted piperazines in vitro.Biochemical pharmacology, 33 9
(1989)
Which 5 - HT receptors are involved in the inhibition of object burying behaviour by 5 - HT uptake inhibitors ?
Winslow Jt, Insel Tr (1990)
Neurobiology of obsessive compulsive disorder: a possible role for serotonin.The Journal of clinical psychiatry, 51 Suppl
D. Hoyer (1988)
Molecular pharmacology and biology of 5-HT1C receptors.Trends in pharmacological sciences, 9 3
N. Darmani, B. Martin, U. Pandey, R. Glennon (1990)
Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactionsPharmacology Biochemistry and Behavior, 37
(1990)
Pharmacological characterisation of ear-scratch response in mice
GARRATINI GARRATINI, MENNINI MENNINI, SAMANIN SAMANIN (1989)
Reduction of food intake by manipulation of central serotoninBr. J. Psychiatr., 155
(1988)
Nonparametric Statistics for the Behavioural Sciences
C. Broekkamp, H. Rijk, Danielle Joly-Gelouin, Kenneth Lloyd (1986)
Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice.European journal of pharmacology, 126 3
G. Kennett, P. Whitton, K. Shah, G. Curzon (1989)
Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists.European journal of pharmacology, 164 3
(1989)
Comparison of DOI - induced scratching and head - twitch behaviours : differential action of 8 - OHDPAT
L. Backus, T. Sharp, D. Grahame-Smith (1990)
Behavioural evidence for a functional interaction between central 5‐HT2 and 5‐HT1A receptorsBritish Journal of Pharmacology, 100
W. Katon (1990)
Chest pain, cardiac disease, and panic disorder.The Journal of clinical psychiatry, 51 Suppl
L. Terlecki, J. Pinel, D. Treit (1979)
Conditioned and unconditioned defensive burying in the ratLearning and Motivation, 10
(1989)
5 - HT 1 c receptor - mediated stimulation of inositol phosphate production in pig choroid plexus . A pharmacological characterisation
S. Auerbach, N. Kamalakannan, J. Rutter (1990)
TFMPP and RU24969 enhance serotonin release rat hipocampusEuropean Journal of Pharmacology, 190
J. Leysen, P. Pauwels (1990)
Central and Peripheral 5-HT2Receptors: Role in Physiological Versus Pathological Conditions
(1989)
The relationship between various animal models of anxiety, fear-related psychiatric symptoms and response to serotonergic drugs
(1988)
Behavioural profile of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) a selective 5-HT2 agonist
S. Auerbach, N. Kamalakannan, J. Rutter (1990)
TFMPP and RU24969 enhance serotonin release from rat hippocampus.European journal of pharmacology, 190 1-2
K. Njung'e, S. Handley (1991)
Evaluation of marble-burying behavior as a model of anxietyPharmacology Biochemistry and Behavior, 38
(1989)
Are TFMPP , mCPP and CGS 12066 selective for 5 - hydroxytryptamine 5 - HT 1 B receptors ?
S. Garattini, T. Mennini, R. Samanin (1989)
Reduction of Food Intake by Manipulation of Central Serotonin Current Experimental ResultsBritish Journal of Psychiatry, 155
1 The effects of 5‐hydroxytryptamine (5‐HT) uptake inhibitors, agonists and antagonists have been evaluated on mouse marble‐burying behaviour, a putative test for anxiolytic agents. The high levels of locomotor activity occurring on first exposure to a circular runway (runway activity) were used as a separate test of non‐specific drug effects. 2 Fluvoxamine, zimeldine, indalpine and citalopram dose‐dependently inhibited burying without affecting runway activity. 5‐Hydroxytryptophan (5‐HTP, with carbidopa), 5‐methoxy‐N,N‐dimethyltryptamine, 8‐hydroxy‐2‐(di‐n‐propylamino) tetralin (8‐OHDPAT), buspirone, gepirone and ipsapirone reduced burying only at doses reducing runway activity. RU 24969 increased runway activity at all effective doses. 1‐(2,5‐Dimethoxy‐4‐iodophenyl)‐2 aminopropane (DOI), 1,‐(3‐trifluoromethylphenyl) piperazine (TFMPP) and l‐(3‐chlorophenyl)‐piperazine (mCPP) potently and differentially reduced burying at doses below those affecting runway activity. 3 5‐HT antagonists only reduced burying at high doses which also reduced runway activity. Burying inhibition by DOI was antagonized by ritanserin, ICI 169 369 and cyproheptadine but not by pindolol or a low (0.25 mg kg−1) dose of metergoline. Burying inhibition by mCPP was not altered by any of these agents except that it was potentiated by pindolol 5 mg kg−1. 4 Zimeldine burying inhibition was potentiated by ritanserin, ICI 169 369, ICS 205–930, cyproheptadine and pindolol. Runway activity was not affected by these drug combinations. 5 Zimeldine was administered in drinking water at a dose of 10 mg kg−1 daily for 21 days. Burying inhibition had disappeared by day 14 and did not recur 24 or 48 h after withdrawal at which times responses to DOI were at control levels. 6 Selective inhibition of marble burying was not found to be a property of 5‐HT‐related putative and actual anxiolytics such as buspirone, gepirone, ipsapirone, ritanserin and ondansetron. Nevertheless it was a general property of both 5‐HT uptake inhibitors and 5‐HT releasing agents; this generality suggests that elevated synaptic 5‐HT could be responsible for the effects of these latter agents. The action of DOI may be attributable to effects at the 5‐HT2 receptor but those of the 5‐HT agonist and releasing agent mCPP, and the uptake inhibitor zimeldine, could not be attributed to effects at any one 5‐HT receptor subtype. This, together with the potentiating effect of several 5‐HT antagonists on the response to zimeldine, raises the possibility of multiple interactions between 5‐HT receptor subtypes.
British Journal of Pharmacology – Wiley
Published: Sep 1, 1991
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.